SCHEDULE OF LECTURES FOR THE 1ST UDAAN NR2CON

Date: 8.30 am to 5.30 PM, Saturday 15th to Monday 17th September 2007

DOGRA HALL AUDITORIUM, INDIAN INSTITUTE OF TECHNOLOGY , HAUZ KHAS, NEW DELHI, INDIA

Complimentary Banquet on Saturday evening for speakers, chairpersons, delegates, organizers and advertisers at IIT Delhi. 
Admission restricted to Invitees with Invitation card (Each card admits One)

Fund-Raising Faculty Dinner on Sunday restricted to Speakers, Special Invitees and those paying Rs.1500/person. 
Admission restricted to Invitees with Invitation card (Each card admits Two; Dress Code: Formal)

Sessions may be Revised from time to time, to give  International Authorities more time to discuss the basics and in-depth latest studies
on pathology, mode of action and results of brain repair techniques in Autism and CP.
Last updated September 12th, 2007

Day 1
Saturday
15th September

0900 1100 INAUGURATION & INTRODUCTORY SESSIONS
0900 0930 Announcer Welcome Song, Announcements & Promo
0930 0940 Dr. Vineet Bhusan Gupta
 Senior Pediatric Neurologist at Apollo Hospital, Delhi. He has a long experience of managing neurodevelopmental disorders 		Welcome delegates and explain the current scenario of Neural Repair in Stroke, head trauma and Neurodevelopmental Disabilities in India
0940 0950 Dr. Arun Mukherjee
Senior Consultant in Internal Medicine, Majeedia Hospital, Hamdard University & Founder Trustee and Director of FSMHP-UDAAN. He pioneered in India the Multimode HBOT-Based Early Medical Intervention Therapy for children with CP, whose results were invited for presentation at the 5th Int.Symp. on HBOT & the Recoverable Brain, Florida, July '06.		 Introduce NR2CON Theme and worldwide advances in Neural Repair
Introduction to FSMHP-UDAAN and its role in bringing Neural Repair to India
0950 1000 Dr. A Mukherjee Showcase Videos & Welcome our Special little guests 
1000 1010 Announcer Welcome all VIPs and Chief Guest onto Stage
Lamp Lighting Ceremony by Chief Guest and Little VIPs
1010 1030 Chief Guest Inauguration Speech
1030 1100 TEA BREAK 
1100 1300 FRANCO INDIAN SESSION on Early Diagnosis & Testing in CP & Autism 
CHAIRPERSON: Dr. R K Parashar
CO-CHAIRPERSON: Dr. N K Aggarwal, Director, Shubham Hospital, New Delhi
1100 1130 Dr. Praveen Suman
Consultant in Developmental Pediatrics at Sir Ganga Ram Hospital, New Delhi		 Early Diagnosis of Neurodevelopmental Disabilities and its therapeutic implications: A Pediatricians perspective
1130 1200 Ms. Tessa Hamblin
Ms. Hamblin has extensive experience in working with persons with cerebral palsy. Initially she developed therapy services for Indian Institute of Cerebral Palsy, which include outpatient services and an early intervention clinic. She received an M.B.E. in 1984 for her work in the field of disability. She is currently involved in training programmes for medical and rehabilitation professionals. She has developed training material in the form of booklets & video for both professionals & parents.		 Early Diagnosis of CP and allied Diseases: A Therapists perspective
1200 1230 Dr. Amit Sen
Senior Consultant, Child & Adolescent Psychiatry, Sitaram Bhartia Institute, Delhi		 Diagnosis of Autism Spectrum disorders
1230 1300 Dr. Kavita Arora
Consultant, Child and Adolescent Psychiatry, Sitaram Bhartia Institute, New Delhi.		 Newer Theories and Concepts in Autism Spectrum Disorders
1300 1400 LUNCH BREAK
1400 1600 SESSION: SPECT Scan & Hyperbaric Oxygen Therapy
CHAIRPERSON:  Dr. Hora, Asst. Prof. & In-Charge, NIMH Delhi
CO-CHAIRPERSON:  (Specialist from NBRC on fMRI)
1400 1500

Dr. J. Michael Uszler
Medical Director at Santa Monica Imaging & Therapy Associates, Inc., Courtesy Staff Physician in Nuclear Medicine at Santa Monica - UCLA Medical Center and Assistant Clinical Professor of Medical and Molecular Pharmacology at UCLA.

Present and near Future of Functional Imaging (SPECT, Functional MRI, etc.) in diagnosis of CNS lesions, with special reference to CP, Autism Spectrum Disorders, Head injury and emotional changes

1500 1600 Dr. Paul Harch
President, Int. Hyperbaric Association, Clinical Asst. Professor, Section of Emergency Medicine at Louisiana State University School of Medicine, New Orleans, Co-Medical Director of the Hyperbaric Medicine Department at St. Charles General Hospital, New Orleans, Clinical and Research Director of the LSU Hyperbaric Medicine Fellowship..		 What is Hyperbaric Oxygen Therapy
How  does it work
Role in reducing edema
Role in reducing penumbra
Role in augmenting Stem cell activation and Neuroplasticity
Role of HBOT in Therapeutics
1600 1730 PLENARY SESSION: Autism: Newer Theories, Genetics, Diagnosis, Brain Scanning and Biochemical Approach
CHAIRPERSON: Dr. Dharmender Kumar, Director, IPH 
CO-CHAIRPERSON: Prof. Ravi Nehru, G B Pant Hospital, Delhi
1600 1730 Dr. Dan Rossignol
On staff at the International Child Development Resource Center (ICDRC), a former Clinical Assistant Professor at the University of Virginia Department of Family Medicine and a Defeat Autism Now! (DAN!) Physician. He is an advisory board member for US Autism and Asperger Association. He is one of the Internationally acclaimed authorities on Biochemical Approach to management of Autism, including the use of HBOT		 Common Biomedical Problems in Autism and Treatment Options
Background: severity of autism in the U.S. , U.K. , and the World.
Brief genetic background and evidence of an environmental contribution to autism.
Metal toxicity, inflammation, oxidative stress, and methylation abnormalities in autism.
Treatment options including chelation, anti-inflammatory medications, anti-oxidants, and other biomedical therapies.
Clinical Investigations of Hyperbaric Oxygen Therapy for Autism
Review the mechanisms of action of hyperbaric oxygen therapy (HBOT) on the pathophysiology of autism including cerebral hypoperfusion, hypoxia, inflammation, and oxidative stress.
Review of 3 studies on HBOT in autism, including a double-blind controlled study of 55 children with autism.
Understand the common improvements and side effects seen with HBOT in autistic individuals.
Review and understand the protocols for treating autistic individuals with HBOT.
1730   TEA AND DISPERSE

Day 2
Sunday
16th September

0900 0950 SESSION: Brain Repair: Traditional & Futuristic Approach to Management 
CHAIRPERSON: Prof. Vinode Puri, HOD, G B Pant Hospital, New Delhi
CO-CHAIRPERSON: Dr.(Ms.) M S Ray
0900 0920 Dr. Shakir Jamil
Professor, Head of Department and Dean of Faculty of Medicine at Hamdard University, New Delhi. He has extensive experience in our ancient heritage of medicinal knowledge, especially Unani Therapies.		 Evaluation of a Unani Formulation for improving Cognitive impairment in children with CP and MR, in children enrolled at UDAAN.
0920 0950 Dr. I C Verma 
Sr. Consultant & Chairman, Dept. of Genetic Medicine, Sir Ganga Ram Hospital, New Delhi 		 Genetic Counseling in Neurodevelopmental Disabilities
0950 1020 Dr. M M Mehndiratta
Professor of Neurology, GB Pant Hospital and Hon. Secy, Ind. Neurological Society		 Stem cell research in India, with especial reference to neurological Disabilities.
1020 1100 Dr. Bernard Brucker
Professor in the Departments of Psychiatry and Behavioral Sciences, Orthopedics and Rehabilitation, and Radiology at the University of Miami-School of Medicine, Director of the Biofeedback Laboratory at University of Miami School of Medicine/Miami Jewish Home & Hospital. 		 Computer Assisted Biofeedback:
How it is done
Animal studies
Physiological effects
Role in Augmenting Neuroplasticity
Application in Stroke, head Injury, etc, with special reference to Stroke and Brain injury
1100 1130 TEA BREAK
1130 1330 PLENARY SESSION: Autism Spectrum Disorder: Medical Advances and Insights
CHAIRPERSON: Prof. Sanjay Wadhwa, HOD PMR at PGIMER, Chandigarh
CO-CHAIRPERSON: Dr. Rajiv Uttam
1130 1300 Dr. James Neubrander
DAN Physician, Edison, New Jersey, USA, is board certified in Environmental Medicine, and Board member for US Autism and Asperger Association. His special interest is in heavy metals, B-12 biochemistry, DAN Protocol and HBOT.

Approach to a child with ASD

Dispelling the myth that Autism is always permanent.

The importance of regulated and specific diet, with balanced micronutrient support

Rehabilitation techniques specific to ASD

DAN protocol: what it means, and what it implies.

HBOT, why it is necessary in ASD, and how much it helps.

Need for, and proper usage of Injection MB12 in ASD

Prognosis of ASD with a balanced multi modal approach
1300 1330

PANEL DISCUSSION ON AUTISM
PANELISTS: Chairperson: Dr. I C Verma
Dr. Dan Rossignal                   Dr. J Neubrander                   Dr.Arun Mukherjee
Dr. Amit Sen                          Dr. Kavita Arora                     Dr. Santosh Kumar
Ms.Manisha Lad                     Ms. Anju Saxena                  Ms. Rajni Verma
                                         
1330 1430 LUNCH BREAK
1430 1730 SESSION: Innovative Interventions for Neurological Damage
CHAIRPERSON:  Dr. Manoj Kumar, Chief Disability Commissioner, GOI
CO-CHAIRPERSON:  Dr. Tarun Sahni
1430 1450 Ms. Shannon Kenitz
Executive Director of the International Hyperbarics Association.		 Mitochondrial Disease: Current scenario of management of MD, including personal experience with her own daughter affected with MD and outcome 5 years later.
1450 1520 Dr. B Brucker Operant Conditioning to augment Neuroplasticity in CP and ADHD 
1520 1550 Dr. Paul Harch Role of HBOT in CP and allied Disorders in children
1550 1650 Dr. Pierre Marois, 
Centre Hospitalier Universitaire Ste-Justine, Montreal, Canada. He carried out the largest published landmark study in CP management published in 110 children, in Lancet 2001, using HBOT at 1.75 ATA using 100% Oxygen versus HBOT at 1.35 ATA using ambient		 Regular vs. mHBOT in management of CP in children
1650 1710 Dr. Arun Mukherjee#, Dr. Shakir Jamil##, Dr. Ajay Kumar* (Presenter), Dr. Ujjwal Kumar*, Dr.Bimal Chopra*, Dr. Sanjay Kumar*, Ms. Premshila Singh*, Ms. Erene Khonglam*, 
Dr. Lallan Kumar* & Dr. Tarun Sahni
# Director & Founder Trustee, FSMHP-UDAAN & Projects, Delhi
## H.O.D. Medicine, Hamdard University, New Delhi
* Team UDAAN		 India's First Controlled Ongoing Study on UDAAN Multimode Therapy of CP, comparing Standard Therapy with the same plus CP-Specific Acupuncture plus 1.3 ATA ambient air HBA or Regular HBOT at 1.5 ATA  or 1.75 ATA
1710 1730 Dr. Arun Mukherjee (Presenter), Prof. Shakir Jamil & Ms. Anju Saxena*
* H.O.D. Autism Project, FSMHP-UDAAN

India's First Study of the Scenario of Autism Spectrum Disorders and need based Medical Interventions in affected children using Standard Therapy, DAN Protocol, MB12, Chelation and mHBOT: A Research Protocol by UDAAN at Delhi (Pending DCI permission).
1730   TEA AND DISPERSE

Day 3
Monday
17th September

0900 0950 SESSION: Government policies and facilities for Persons with Disability
CHAIRPERSON: Gen. Cardozo, Chairperson, RCI
CO-CHAIRPERSON:  Dr. Prasenjit Mazumdar, Social Welfare Officer, AIJNIHH, Delhi
0900 0950 Ms. Aloka Guha
Ex-Chairperson, National Trust for the Welfare of Persons with Autism, CP and MR. She is an authority on various policies of the Government for helping persons with disabilities and has always extended a helping hand to enable disabled persons.		 Government policies and benefits extended to persons with CP, Autism, and Mental Retardation
0950 1010 TEA BREAK
1010 1210 SESSION: Therapy Interventions & Outcome in CP
CHAIRPERSON: Ms. Poonam Natarajan, Chairperson, National Trust for Welfare of Persons with Autism, CP & MH
CO-CHAIRPERSON:  Ms. Ona P Desai, Reader, Dept. of Allied Sciences, Hamdard University
1010 1030 Ms. Karin Heirstraeten
President of Caresharing Foundation in Netherlands. She has been associated with special need children as a therapist. Her talk at the 5th Int. Symposium on HBOT and the Recoverable Brain, on balanced Exercise Program in CP children given HBOT, was highly appreciated.

Balanced exercise program along with HBOT in children with CP
1030 1100 Dr. Anjali Joshi 
Associate Professor of Occupational Therapy School and Center at K.E.M.Hospital Mumbai. She has extensive experience in management of Sensory Processing Deficits in Autism.

Sensory Integration Therapy in Cerebral Palsy
1100 1130 Dr. Mathew Verghese
Senior Orthopedic Surgeon, St. Stephens Hospital, Delhi		 Role of Surgical interventions and Nerve Block / Botulinum Therapy in Spasticity in CP /  Stroke
1130 1200 Ms. Usha Grover
Asstt. Prof. in Special Education at the National Institute for the Mentally Handicapped, Regional Centre, New Delhi. After Post Graduation in Education she underwent intensive 1 yr diploma course in Special Education in University of Birmingham, U.K in 1984 and her Ph.D from Jamia Milia Islamia in the year 2005.

A Comparative study of stress, expectation and awareness level among parents of Individuals with CP, Multiple Disabilities & Autism
1200 1330 SESSION: Therapy Interventions & Outcome in Autism
CHAIRPERSON: Dr. Anjali Joshi
CO-CHAIRPERSON: Ms. Anju Saxena
1200 1230 Dr. S Mokashi 
Prof. Of Occupational Therapy at NRITAR, Bhubaneshwar. He has extensive expertise on the role of Sensory Integration Therapy in CP

Sensory Integration Therapy in Autism
1230 1300 Ms. Manisha Lad 
Certified Nutritional Consultant (CNC), resident of New Jersey, USA for last 9 yrs with husband and her only son: an autistic child. She privately consults with a Holisitic Center in New York to help parents implement various Bio-Medical interventions (GFCF Diet, Vitamins, Supplements, MB12 shots, Chelation, HBOT 

Efficacy of Biochemical Approach in Autism: A practical and personal observation from a professional and mother of an autistic child.
1300 1400 LUNCH BREAK 
1400 1630 SESSION: Medical & Technical Synergy for Speech, Communication and Assistive Devices
CHAIRPERSON: Prof. Subhash Wadhwa, Prof. of IIT, Delhi & Principal, GGSIPU, Delhi.
CO-CHAIRPERSON: Dr. V P Shah, Associate Prof., Ali Yuvar Jung Inst. for Hearing Handicapped, Delhi
1400 1430 Dr. Nandini Chatterjee Singh
Asst. Prof. National Brain Research Centre, Haryana, INDIA. She is doing pioneering basic research on Speech Mechanisms and Language and central auditory processing, Language and learning disabilities, and Structure and representation of sound. 		 Basic Research on Speech Mechanisms, with special reference to special need persons
1430 1500 Dr. Sudha Kaul 
Specializes in Alternative Augmentative Communication. Her work at Kolkata has brought her International acclaim for improving communication ability to countless special need adults and children with neurological disabilities.

Alternative  & Augmentative Communication (AAC) in the management of Neurodevelopmental disabilities in children
1500 1530 Dr. Pratibha Karanth is a pioneer in the field of Speech-Language Pathology in India for last 30 years. She worked with Tito aka Rajrishi Mukhophadyay, a gifted autistic child who could talk about his autism. Subsequently, she developed the Communication DEALL program for children with communication disorders such as Specific Language Impairment (SLI), Pervasive Developmental Disorder (PDD) / Autism (ASD) and Developmental Verbal Dyspraxia (DVD). 

Communication DEALL Program (Developmental Eclectic Approach to Language Learning) for children with communication disorders like Autism
1530 1600 Dr. Shobhan Saha 
Assoc. Prof, Dept. of Occupational Therapy at Manipal Medical College, India. He has done extensive research in the development of Assistive Technologies for helping improve the quality of life of adults and children with Cerebral Palsy.

Assistive Devices for Neuro-developmental disabilities especially Locomotor variety
1600 1610 Priya Martin
OT, Dr. Mary Varghese Institute of Rehabilitation, CMC, Vellore		 Modern Assistive Devices in the management of Spinal Injury
1610 1630   Cochlear Implant to enhance hearing impairment in disabled persons
1630 1700

VOTE OF THANKS: Dr. Arun Mukherjee
1700   TEA AND DISPERSE
Click here to return to NR2CON Home Page Click here to go to the UDAAN Website Home Page